Best Practice & Research Clinical Haematology
Volume 21, Issue 4 , Pages 659-666, December 2008

What is the role of arsenic in newly diagnosed APL?

  • Martin S. Tallman, MD (Professor of Medicine, Feinberg School of Medicine, Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL)

      Affiliations

    • Corresponding Author InformationTel.: +312 695 6180; Fax: +312 695 6189.

Northwestern University, Feinberg School of Medicine, Division of Hematology/Oncology, Department of Medicine, 676 N. St. Clair Street, Suite 850, Chicago, IL 60611-2927, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(08)00088-1

doi:10.1016/j.beha.2008.09.002

Best Practice & Research Clinical Haematology
Volume 21, Issue 4 , Pages 659-666, December 2008

Article Tools